• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病和肥胖症中的高密度脂蛋白改变

High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.

作者信息

Denimal Damien, Monier Serge, Bouillet Benjamin, Vergès Bruno, Duvillard Laurence

机构信息

INSERM, UMR1231, University of Burgundy, 21000 Dijon, France.

Department of Biochemistry, CHU Dijon Bourgogne, 21000 Dijon, France.

出版信息

Metabolites. 2023 Feb 9;13(2):253. doi: 10.3390/metabo13020253.

DOI:10.3390/metabo13020253
PMID:36837872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9967905/
Abstract

Alterations affecting high-density lipoproteins (HDLs) are one of the various abnormalities observed in dyslipidemia in type 2 diabetes mellitus (T2DM) and obesity. Kinetic studies have demonstrated that the catabolism of HDL particles is accelerated. Both the size and the lipidome and proteome of HDL particles are significantly modified, which likely contributes to some of the functional defects of HDLs. Studies on cholesterol efflux capacity have yielded heterogeneous results, ranging from a defect to an improvement. Several studies indicate that HDLs are less able to inhibit the nuclear factor kappa-B (NF-κB) proinflammatory pathway, and subsequently, the adhesion of monocytes on endothelium and their recruitment into the subendothelial space. In addition, the antioxidative function of HDL particles is diminished, thus facilitating the deleterious effects of oxidized low-density lipoproteins on vasculature. Lastly, the HDL-induced activation of endothelial nitric oxide synthase is less effective in T2DM and metabolic syndrome, contributing to several HDL functional defects, such as an impaired capacity to promote vasodilatation and endothelium repair, and difficulty counteracting the production of reactive oxygen species and inflammation.

摘要

影响高密度脂蛋白(HDL)的改变是2型糖尿病(T2DM)和肥胖症血脂异常中观察到的各种异常之一。动力学研究表明,HDL颗粒的分解代谢加速。HDL颗粒的大小、脂质组和蛋白质组均发生显著改变,这可能是导致HDL一些功能缺陷的原因。关于胆固醇流出能力的研究结果不一,从缺陷到改善都有。多项研究表明,HDL抑制核因子κB(NF-κB)促炎途径的能力较弱,随后单核细胞在内皮上的黏附及其向内皮下间隙的募集也会减少。此外,HDL颗粒的抗氧化功能减弱,从而促进氧化型低密度脂蛋白对血管系统的有害作用。最后,在T2DM和代谢综合征中,HDL诱导的内皮型一氧化氮合酶激活效果较差,这导致了HDL的多种功能缺陷,如促进血管舒张和内皮修复的能力受损,以及难以对抗活性氧的产生和炎症反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/f85ede08916b/metabolites-13-00253-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/6efbb994cc3a/metabolites-13-00253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/6311aa206e45/metabolites-13-00253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/8d64e59441d2/metabolites-13-00253-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/f85ede08916b/metabolites-13-00253-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/6efbb994cc3a/metabolites-13-00253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/6311aa206e45/metabolites-13-00253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/8d64e59441d2/metabolites-13-00253-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9967905/f85ede08916b/metabolites-13-00253-g004.jpg

相似文献

1
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.2型糖尿病和肥胖症中的高密度脂蛋白改变
Metabolites. 2023 Feb 9;13(2):253. doi: 10.3390/metabo13020253.
2
Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.血管生成素样蛋白4是高密度脂蛋白(HDL)的一个组成成分,参与非糖尿病受试者和2型糖尿病患者的HDL代谢及功能。
J Am Heart Assoc. 2017 Jun 23;6(6):e005973. doi: 10.1161/JAHA.117.005973.
3
Lipid modification in type 2 diabetes: the role of LDL and HDL.2 型糖尿病中的脂质修饰:LDL 和 HDL 的作用。
Fundam Clin Pharmacol. 2009 Dec;23(6):681-5. doi: 10.1111/j.1472-8206.2009.00739.x. Epub 2009 Jul 24.
4
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.高密度脂蛋白胆固醇水平对 2 型糖尿病患者循环单核细胞血管生成细胞功能的影响。
Cardiovasc Diabetol. 2018 Jun 5;17(1):78. doi: 10.1186/s12933-018-0720-1.
5
Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion.在 2 型糖尿病患者中,与冠状动脉疾病相关的氨甲酰化高密度脂蛋白:患者的氨甲酰化高密度脂蛋白促进单核细胞黏附。
J Transl Med. 2020 Dec 3;18(1):460. doi: 10.1186/s12967-020-02623-2.
6
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.胰岛素抵抗和2型糖尿病中高密度脂蛋白代谢及胆固醇逆向转运的改变:脂解酶、卵磷脂胆固醇酰基转移酶和脂质转运蛋白的作用
Eur J Clin Invest. 2003 Dec;33(12):1051-69. doi: 10.1111/j.1365-2362.2003.01263.x.
7
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.LpA-I:A-II颗粒的耗竭增强了家族性卵磷脂胆固醇酰基转移酶缺乏症中高密度脂蛋白介导的内皮保护作用。
J Lipid Res. 2017 May;58(5):994-1001. doi: 10.1194/jlr.P072371. Epub 2017 Mar 28.
8
Postprandial lipoproteins and the molecular regulation of vascular homeostasis.餐后脂蛋白与血管稳态的分子调控。
Prog Lipid Res. 2013 Oct;52(4):446-64. doi: 10.1016/j.plipres.2013.06.001. Epub 2013 Jun 15.
9
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes.高密度脂蛋白在1型和2型糖尿病中的抗氧化及抗炎功能
Antioxidants (Basel). 2023 Dec 28;13(1):57. doi: 10.3390/antiox13010057.
10
Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications.2型糖尿病中功能失调的高密度脂蛋白:分子机制与治疗意义
J Clin Med. 2021 May 21;10(11):2233. doi: 10.3390/jcm10112233.

引用本文的文献

1
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.高密度脂蛋白,第1部分。流行病学、抗动脉粥样硬化作用以及旨在提高其血清水平的治疗方法。
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
2
Association Between CTLA4 Level and Obesity, Dyslipidemia, and Type 2 Diabetes Mellitus.细胞毒性T淋巴细胞相关抗原4水平与肥胖、血脂异常及2型糖尿病之间的关联
Med Arch. 2025;79(2):117-121. doi: 10.5455/medarh.2025.79.117-121.
3
Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study.

本文引用的文献

1
Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk.全自动胆固醇摄取能力免疫分析检测法评估高密度脂蛋白功能和心血管疾病风险
Sci Rep. 2023 Feb 2;13(1):1899. doi: 10.1038/s41598-023-28953-x.
2
HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally Distinct.免疫亲和法、超速离心法或沉淀法分离的高密度脂蛋白在组成和功能上是不同的。
J Lipid Res. 2022 Dec;63(12):100307. doi: 10.1016/j.jlr.2022.100307. Epub 2022 Oct 29.
3
Scavenging dicarbonyls with 5'-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance.
临床规定的依列卡福-替扎卡福-依伐卡福治疗12 - 18个月后的胆固醇和甘油三酯浓度 - PROMISE子研究
J Clin Transl Endocrinol. 2025 Apr 2;40:100391. doi: 10.1016/j.jcte.2025.100391. eCollection 2025 Jun.
4
Elevated high-density lipoprotein triglycerides increase atherosclerotic risk.高密度脂蛋白甘油三酯升高会增加动脉粥样硬化风险。
J Lipid Res. 2025 Mar 29;66(5):100791. doi: 10.1016/j.jlr.2025.100791.
5
The nonlinear relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol and the risk of diabetic kidney disease in patients with type 2 diabetes mellitus.2型糖尿病患者中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与糖尿病肾病风险之间的非线性关系。
Front Med (Lausanne). 2025 Feb 19;12:1492483. doi: 10.3389/fmed.2025.1492483. eCollection 2025.
6
High-Density Lipoprotein Lipid and Protein Cargo and Cholesterol Efflux Capacity Before and After Bariatric Surgery.减肥手术前后高密度脂蛋白的脂质、蛋白质成分及胆固醇流出能力
Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):e48-e62. doi: 10.1161/ATVBAHA.124.321686. Epub 2025 Jan 2.
7
U-shaped association of uric acid to HDL cholesterol ratio (UHR) with ALL-cause and cardiovascular mortality in diabetic patients: NHANES 1999-2018.糖尿病患者中尿酸与高密度脂蛋白胆固醇比值(UHR)与全因死亡率和心血管死亡率的U型关联:1999 - 2018年美国国家健康与营养检查调查(NHANES)
BMC Cardiovasc Disord. 2024 Dec 27;24(1):744. doi: 10.1186/s12872-024-04436-3.
8
Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity.胆固醇酯转移蛋白抑制:降低发病风险和促进长寿的途径。
Curr Opin Lipidol. 2024 Dec 1;35(6):303-309. doi: 10.1097/MOL.0000000000000955. Epub 2024 Oct 17.
9
Patterns of Lipid Abnormalities in Obesity: A Comparative Analysis in Normoglycemic and Prediabetic Obese Individuals.肥胖症患者脂质异常模式:正常血糖和糖尿病前期肥胖个体的比较分析
J Pers Med. 2024 Sep 15;14(9):980. doi: 10.3390/jpm14090980.
10
Platelet/High-Density Lipoprotein Ratio (PHR) Predicts Type 2 Diabetes in Obese Patients: A Retrospective Study.血小板/高密度脂蛋白比值(PHR)预测肥胖患者的2型糖尿病:一项回顾性研究。
Healthcare (Basel). 2024 Aug 3;12(15):1540. doi: 10.3390/healthcare12151540.
用 5'-O-戊基-吡哆醛肟清除二羰基化合物可增加高密度脂蛋白净胆固醇流出能力,并减轻动脉粥样硬化和胰岛素抵抗。
Mol Metab. 2023 Jan;67:101651. doi: 10.1016/j.molmet.2022.101651. Epub 2022 Dec 5.
4
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.载脂蛋白 C1 在脂蛋白代谢、动脉粥样硬化和糖尿病中的作用:系统评价。
Cardiovasc Diabetol. 2022 Dec 5;21(1):272. doi: 10.1186/s12933-022-01703-5.
5
High levels of oxidized fatty acids in HDL impair the antioxidant function of HDL in patients with diabetes.高密度脂蛋白中高水平的氧化脂肪酸会损害糖尿病患者高密度脂蛋白的抗氧化功能。
Front Endocrinol (Lausanne). 2022 Oct 20;13:993193. doi: 10.3389/fendo.2022.993193. eCollection 2022.
6
High-density lipoprotein revisited: biological functions and clinical relevance.高密度脂蛋白再探:生物学功能与临床相关性。
Eur Heart J. 2023 Apr 21;44(16):1394-1407. doi: 10.1093/eurheartj/ehac605.
7
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control.1 型糖尿病中的高密度脂蛋白功能:血糖控制改善后,与高密度脂蛋白氨甲酰化降低相关的胆固醇外排能力增强。
Cardiovasc Diabetol. 2022 Aug 12;21(1):154. doi: 10.1186/s12933-022-01591-9.
8
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation.前蛋白转化酶枯草溶菌素9抑制剂对家族性高胆固醇血症患者高密度脂蛋白胆固醇流出及血清胆固醇负荷能力的影响:多脂质中心真实世界评估
Front Mol Biosci. 2022 Jul 19;9:925587. doi: 10.3389/fmolb.2022.925587. eCollection 2022.
9
Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes.从健康受试者到糖尿病前期和2型糖尿病患者,高密度脂蛋白脂质组的渐进性、定性和定量改变。
Metabolites. 2022 Jul 25;12(8):683. doi: 10.3390/metabo12080683.
10
Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome.采用脂质组学方法研究代谢综合征合并中心性肥胖患者的高密度脂蛋白代谢。
Int J Mol Sci. 2022 Jun 17;23(12):6786. doi: 10.3390/ijms23126786.